Mega Genomics (HKSE:06667) Days Payable : 259.53 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Mega Genomics Days Payable?

Mega Genomics's average Accounts Payable for the six months ended in Dec. 2023 was HK$45.8 Mil. Mega Genomics's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$32.2 Mil. Hence, Mega Genomics's Days Payable for the six months ended in Dec. 2023 was 259.53.

The historical rank and industry rank for Mega Genomics's Days Payable or its related term are showing as below:

HKSE:06667' s Days Payable Range Over the Past 10 Years
Min: 96.87 Med: 142.94 Max: 230.13
Current: 230.13

During the past 5 years, Mega Genomics's highest Days Payable was 230.13. The lowest was 96.87. And the median was 142.94.

HKSE:06667's Days Payable is ranked better than
80.49% of 205 companies
in the Medical Diagnostics & Research industry
Industry Median: 67.81 vs HKSE:06667: 230.13

Mega Genomics's Days Payable increased from Dec. 2022 (201.00) to Dec. 2023 (259.53). It may suggest that Mega Genomics delayed paying its suppliers.

Mega Genomics Days Payable Historical Data

The historical data trend for Mega Genomics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Genomics Days Payable Chart

Mega Genomics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

96.87

122.19

142.94

190.39

217.32

Mega Genomics Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial			139.89	170.47	201.00	216.39	259.53

Competitive Comparison of Mega Genomics's Days Payable

For the Diagnostics & Research subindustry, Mega Genomics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mega Genomics's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mega Genomics's Days Payable distribution charts can be found below:

* The bar in red indicates where Mega Genomics's Days Payable falls into.

Mega Genomics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Mega Genomics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (38.814	+	43.249)	/	2 )	/	68.913	*	365
=	41.0315					/	68.913	*	365
=	217.32

Mega Genomics's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (48.285	+	43.249)	/	2 )	/	32.183	*	365 / 2
=	45.767					/	32.183	*	365 / 2
=	259.53

Mega Genomics Days Payable Related Terms

Thank you for viewing the detailed overview of Mega Genomics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Mega Genomics (HKSE:06667) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mega Genomics Ltd (HKSE:06667) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

North Garden Road, 401 Health Work, Haidian District, Beijing, CHN

Website

https://www.megagenomics.cn

Mega Genomics Ltd is a genetic testing platform company in China with a focus on consumer genetic testing and cancer screening services. The company has launched dozens of testing services, covering a wide range of fields such as nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, cancer screening and infectious disease diagnosis, to meet consumers' growing preventive medical needs.

Executives

Guo Meiling	2101 Beneficial owner
Lin Lin	2101 Beneficial owner
Yu Rong	2501 Other
Infinite Galaxy Health Limited	2101 Beneficial owner
Mei Nian Investment Limited	2101 Beneficial owner
Kastle Limited	2501 Other
Mega Marvelous Limited	2501 Other
Yurong Technology Limited	2101 Beneficial owner
Niu Zhencai	2201 Interest of corporation controlled by you
Mei Nian Da Jian Kang Chan Ye Kong Gu Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing He He Heng Ye Ke Ji You Xian Gong Si	2201 Interest of corporation controlled by you
Bei Jing Shi Ji Yu Neng Ke Ji You Xian Gong Si	2501 Other
Tian Jin Shi Ji Yu Neng Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner

Mega Genomics (HKSE:06667) Headlines

No Headlines